Search

Displaying results 7451 - 7460 of 9313 in total
  1. Drug

    Fiacitabine

    go.drugbank.com/drugs/DB12901
    Investigational

    Fiacitabine has been used in trials studying the treatment of HIV Infections and Cytomegalovirus Infections.

  2. Drug

    4-isothioureidobutyronitrile

    go.drugbank.com/drugs/DB13010
    Investigational

    Thioureidobutyronitrile has been used in trials studying the treatment of Solid Tumors and Ovarian cancer.

  3. Drug

    Lodenafil carbonate

    go.drugbank.com/drugs/DB11927
    Investigational

    Lodenafil carbonate has been used in trials studying the treatment of Coronaropathy and Erectile Dysfunction.

  4. Drug

    AZD-4818

    go.drugbank.com/drugs/DB12002
    Investigational

    AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD).

  5. Drug

    Fosdagrocorat

    go.drugbank.com/drugs/DB12198
    Investigational

    Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.

  6. Drug

    Begacestat

    go.drugbank.com/drugs/DB12263
    Investigational

    Begacestat has been used in trials studying the treatment and basic science of Alzheimer Disease.

  7. Drug

    Edicotinib

    go.drugbank.com/drugs/DB12504
    Investigational

    JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.

  8. Drug

    AZD-9056

    go.drugbank.com/drugs/DB12594
    Investigational

    AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis.

  9. Drug

    Alfaxalone

    go.drugbank.com/drugs/DB11371
    ExperimentalVet approved

    Along with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin. … It is used in veterinary practice under the trade name Alfaxan, and is licensed for use in both dogs and cats.

  10. Drug

    CTS-21166

    go.drugbank.com/drugs/DB06073
    Investigational

    CTS-21166 is the only BACE1 inhibitor that has passed Phase I clinical trial thus far. … a transition-state analog inhibitor (structure is currently undisclosed) with excellent properties in brain penetration, selectivity, metabolic stability, and oral availability; all of these have met the